Brief: Eloxx Pharmaceuticals Provides Enrollment Update For Ongoing Phase 2 Clinical Studies For Cystic Fibrosis

Eloxx Pharmaceuticals

06/07/2021 21:17

July 6 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS PROVIDES ENROLLMENT UPDATE FOR
ONGOING
PHASE 2 CLINICAL STUDIES FOR CYSTIC FIBROSIS
    * ELOXX PHARMACEUTICALS INC - BASED ON ENROLLMENT TO DATE,
ELOXX
EXPECTS TO PRESENT DATA FROM FIRST FOUR TREATMENT ARMS OF STUDY
IN Q4 OF THIS YEAR
    * ELOXX PHARMACEUTICALS INC - ELOXX WILL CONTINUE TO ENROLL
ADDITIONAL PATIENTS TO SUPPORT PHASE 3 CLINICAL TRIAL PLANNING

Source text for Eikon:  ID:nGNX9hcQK0 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))